文献速递心外重症与机械循环支持瓣膜外科

左心室辅助装置植入同期行三尖瓣手术的EUROMACS倾向评分匹配分析

Outcomes after tricuspid valve surgery concomitant with left ventricular assist device implantation in the EUROMACS registry: a propensity score matched analysis.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

基于EUROMACS注册数据,3323例成人LVAD植入患者中299例(9%)同期行TVS,经倾向评分匹配后比较258对患者。匹配人群住院死亡、正性肌力支持天数、临时右心室辅助装置植入及住院时长相当,TVS组ICU停留更长(11 vs 15天;P=0.026);晚期死亡、非计划再入院及右心衰竭累积发生率相当。同期TVS术后即刻中重度TR概率更低(33% vs 70%;P=0.001),但无TVS组TR下降更快(P=0.030),随访1.5年内两组中重度TR概率相当。

要点

  • 匹配后同期TVS未改善LVAD患者临床结局。
  • TVS组ICU停留更长(11 vs 15天;P=0.026)。
  • TVS早期降低TR但1.5年内差异消失。

核心结论

  • 在匹配患者中,LVAD植入同期行TVS似乎不带来更好的临床结局。
  • 同期TVS显著降低LVAD植入后早期TR,但随访期间TR概率差异消失。

研究设计与样本

  • 基于欧洲机械循环支持患者注册登记(EUROMACS)的回顾性队列研究。
  • 共3323例成人患者接受LVAD植入,其中299例(9%)同期行TVS。
  • 采用倾向评分匹配策略,匹配后258例无TVS患者与258例TVS患者进行比较。

主要发现

  • 匹配人群中,住院死亡、正性肌力支持天数、临时右心室辅助装置植入及住院时长在两组间相当。
  • TVS组ICU停留时间更长(11 vs 15天;P=0.026)。
  • 晚期死亡(P=0.17)、非计划再入院累积发生率(P=0.15)及右心衰竭(P=0.55)在两组间相当。
  • 匹配人群中,术后即刻中重度TR概率TVS组低于无TVS组(33% vs 70%;P=0.001)。
  • 无TVS组中重度TR概率下降更快(P=0.030),随访1.5年内两组中重度TR概率相当。

临床怎么用

  • LVAD植入同期TVS应个体化决策,不应期望其改善总体临床结局。
  • 同期TVS可降低早期TR,但需权衡ICU停留延长等围术期负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Tricuspid regurgitation (TR) is common in patients receiving a left ventricular assist device (LVAD). Controversy exists as to whether concomitant tricuspid valve surgery (TVS) is beneficial in currently treated patients. Therefore, our goal was to investigate the effect of TVS concomitant with a LVAD implant. METHODS: The European Registry for Patients with Mechanical Circulatory Support was used to identify adult patients. Matched patients with and without concomitant TVS were compared using a propensity score matching strategy. RESULTS: In total, 3323 patients underwent LVAD implantation of which 299 (9%) had TVS. After matching, 258 patients without TVS were matched to 258 patients with TVS. In the matched population, hospital deaths, days on inotropic support, temporary right ventricular assist device implants and hospital stay were comparable, whereas stay in the intensive care unit was higher in the TVS cohort (11 vs 15 days; P = 0.026). Late deaths (P = 0.17), cumulative incidence of unexpected hospital readmission (P = 0.15) and right heart failure (P = 0.55) were comparable between patients with and without concomitant TVS. In the matched population, probability of moderate-to-severe TR immediately after surgery was lower in patients with concomitant TVS compared to patients without TVS (33% vs 70%; P = 0.001). Nevertheless, the probability of moderate-to-severe TR decreased more quickly in patients without TVS (P = 0.030), resulting in comparable probabilities of moderate-to-severe TR within 1.5 years of follow-up. CONCLUSIONS: In matched patients, TVS concomitant with LVAD implant does not seem to be associated with better clinical outcomes. Concomitant TVS reduced TR significantly early after LVAD implant; however, differences in probability of TR disappeared during the follow-up period.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Veen KM, Caliskan K, de By TMMH, et al. Outcomes after tricuspid valve surgery concomitant with left ventricular assist device implantation in the EUROMACS registry: a propensity score matched analysis. Eur J Cardiothorac Surg. 2019. PMID: 31321431. doi:10.1093/ejcts/ezz208

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。